Using special materials to help brain cells recover after injury
Glycopolymer Biomaterials for Regulating Adaptive Reprogramming in Glia
This study is looking at how special brain cells react to injuries and how new materials can help them heal better, which could lead to improved treatments for people recovering from strokes or brain injuries.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boston University (Charles River Campus) NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10996492 on NIH RePORTER |
What this research studies
This research focuses on understanding how glial cells in the brain respond to injuries and how they can be influenced by new biomaterials. By developing glycan-derived biomaterials, the research aims to stimulate glial cells to support recovery after strokes and improve integration with neural devices. The approach involves testing different chemical properties and mechanical characteristics of these materials to see how they can enhance the healing process in the central nervous system. Patients may benefit from advancements in treatments that promote better recovery and functionality after brain injuries.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who have experienced strokes or other central nervous system injuries.
Not a fit: Patients with non-CNS related injuries or conditions may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved recovery strategies for patients with brain injuries, enhancing their healing and rehabilitation.
How similar studies have performed: Other research has shown promise in using biomaterials to influence glial cell behavior, suggesting that this approach could be effective.
Where this research is happening
Boston, United States
- Boston University (Charles River Campus) — Boston, United States (Active)
Researchers
- Principal investigator: Dubois, Eric — Boston University (Charles River Campus)
- Study coordinator: Dubois, Eric
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.